Travere Therapeutics, Inc. (TVTX)

CIK 1438533 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Travere Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002862
Nov 2, 202610-Q0001438533-26-000077
Nov 2, 20268-K0001438533-26-000074
Oct 19, 202640001763494-26-000008
Oct 15, 20261440001950047-26-010273
Sep 21, 20268-K0001438533-26-000068
Sep 17, 202640001698262-26-000005
Sep 17, 202640001902368-26-000008
Sep 17, 202640001943192-26-000006
Sep 17, 202640001283303-26-000010
Sep 17, 202640001763494-26-000007
Sep 17, 202640001789617-26-000004
Sep 17, 20261440001950047-26-009642
Sep 17, 202640001882909-26-000004
Sep 17, 20261440001950047-26-009625
Sep 16, 20261440001950047-26-009576
Sep 16, 20261440001950047-26-009577
Sep 16, 20261440001950047-26-009566
Sep 15, 20261440001950047-26-009521
Sep 15, 20261440001950047-26-009510
Sep 15, 20261440001950047-26-009523
Sep 15, 20261440001950047-26-009520
Sep 15, 20261440001950047-26-009513
Sep 15, 20261440001950047-26-009503
Sep 15, 20261440001950047-26-009488